Risk of hypersensitivity pneumonitis and other interstitial lung diseases following organic dust exposure.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: British Medical Assn Country of Publication: England NLM ID: 0417353 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3296 (Electronic) Linking ISSN: 00406376 NLM ISO Abbreviation: Thorax Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : British Medical Assn.
    • Subject Terms:
      Alveolitis, Extrinsic Allergic*/epidemiology ; Alveolitis, Extrinsic Allergic*/etiology ; Dust* ; Lung Diseases, Interstitial*/epidemiology ; Lung Diseases, Interstitial*/etiology ; Occupational Exposure*/adverse effects ; Occupational Diseases*/epidemiology ; Occupational Diseases*/etiology; Humans ; Denmark/epidemiology ; Male ; Female ; Middle Aged ; Incidence ; Adult ; Endotoxins/adverse effects ; Endotoxins/analysis ; Risk Factors
    • Abstract:
      Background: Organic dust is associated with hypersensitivity pneumonitis, and associations with other types of interstitial lung disease (ILD) have been suggested. We examined the association between occupational organic dust exposure and hypersensitivity pneumonitis and other ILDs in a cohort study.
      Methods: The study population included all residents of Denmark born in 1956 or later with at least 1 year of gainful employment since 1976. Incident cases of hypersensitivity pneumonitis and other ILDs were identified in the Danish National Patient Register 1994-2015. Job exposure matrices were used to assign individual annual levels of exposure to organic dust, endotoxin and wood dust from 1976 to 2015. We analysed exposure-response relations by different exposure metrics using a discrete-time hazard model.
      Results: For organic dust, we observed increasing risk with increasing cumulative exposure with incidence rate ratios (IRR) per 10 unit-years of 1.19 (95% CI 1.12 to 1.27) for hypersensitivity pneumonitis and 1.04 (95% CI 1.02 to 1.06) for other ILDs. We found increasing risk with increasing cumulative endotoxin exposure for hypersensitivity pneumonitis and other ILDs with IRRs per 5000 endotoxin units/m 3 -years of 1.55 (95% CI 1.38 to 1.73) and 1.09 (95% CI 1.00 to 1.19), respectively. For both exposures, risk also increased with increasing duration of exposure and recent exposure. No increased risks were observed for wood dust exposure.
      Conclusion: Exposure-response relations were observed between organic dust and endotoxin exposure and hypersensitivity pneumonitis and other ILDs, with lower risk estimates for the latter. The findings indicate that organic dust should be considered a possible cause of any ILD.
      Trial Registration Number: j.no.: 1-16-02-196-17.
      Competing Interests: Competing interests: EB has received payment for lectures from Daiichi-Sankyo, Boehringer Ingelheim, AstraZeneca and Hoffmann-la-Roche and support for attending meetings from Boehringer Ingelheim. VS has been Chair of the Danish Quality Committee for Occupational Exposure Limits of the Danish Working Environment Authority from 2016 to 30 June 2022. MBA has received grants from the Danish Center for Lung Cancer Research, Innovation Fund Denmark and AI Signature funds from the Danish government and has received payment for lectures from Boehringer Ingelheim. HK has received a grant from Industrial Minerals Association Europe for managing the IMA-DUST Monitoring Programme. All other authors have nothing to disclose.
      (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
    • References:
      Ann Work Expo Health. 2023 Jul 6;67(6):758-771. (PMID: 37167588)
      Environ Res. 2022 Mar;204(Pt D):112404. (PMID: 34838572)
      Eur Respir J. 2016 Sep;48(3):818-25. (PMID: 27230447)
      Thorax. 2022 May;77(5):470-476. (PMID: 34593614)
      Ann Occup Hyg. 2003 Apr;47(3):187-200. (PMID: 12639832)
      Am J Respir Crit Care Med. 1998 Feb;157(2):512-7. (PMID: 9476866)
      Lancet. 2022 Sep 3;400(10354):769-786. (PMID: 35964592)
      Int J Tuberc Lung Dis. 2017 Jan 1;21(1):107-112. (PMID: 28157473)
      Int J Epidemiol. 2019 Oct 1;48(5):1413-1413k. (PMID: 31730707)
      J Expo Sci Environ Epidemiol. 2015 Mar-Apr;25(2):123-37. (PMID: 24280684)
      Am J Respir Crit Care Med. 2019 Jun 1;199(11):1312-1334. (PMID: 31149852)
      Sarcoidosis Vasc Diffuse Lung Dis. 2015 Aug 03;32 Suppl 1:4-9. (PMID: 26237436)
      Am J Respir Crit Care Med. 2019 Aug 1;200(3):301-308. (PMID: 31150272)
      Int J Occup Environ Health. 2014 Apr-Jun;20(2):167-73. (PMID: 24999852)
      Ann Occup Hyg. 2015 Mar;59(2):142-57. (PMID: 25389370)
      Respir Med. 2021 Oct;187:106548. (PMID: 34352562)
      J Occup Environ Hyg. 2006 Jun;3(6):301-7. (PMID: 16621767)
      Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. (PMID: 32706311)
      Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):310-9. (PMID: 15992841)
      Am J Respir Crit Care Med. 2001 Jun;163(7):1534-9. (PMID: 11401869)
      Am J Ind Med. 2021 Apr;64(4):251-257. (PMID: 33547652)
      Occup Environ Med. 1998 Oct;55(10):651-6. (PMID: 9930084)
      Occup Environ Med. 2010 Jan;67(1):67-71. (PMID: 20029026)
      Ann Am Thorac Soc. 2015 Jul;12(7):1013-21. (PMID: 26010749)
      Stat Med. 2010 Apr 30;29(9):1037-57. (PMID: 20087875)
      Am J Epidemiol. 2000 Aug 15;152(4):307-15. (PMID: 10968375)
      Ann Agric Environ Med. 2010;17(1):29-44. (PMID: 20684478)
      Int J Occup Environ Med. 2012 Jul;3(3):107-16. (PMID: 23022860)
      ERJ Open Res. 2019 Oct 21;5(4):. (PMID: 31649947)
      J Occup Environ Med. 2017 Nov;59(11):e221-e226. (PMID: 28938261)
      Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. (PMID: 21775347)
      Respir Med. 2014 May;108(5):793-9. (PMID: 24636811)
      Thorax. 2020 Oct;75(10):864-869. (PMID: 32660982)
      Respir Med. 2007 Oct;101(10):2207-12. (PMID: 17628464)
      Clin Allergy. 1987 Mar;17(2):143-51. (PMID: 3581462)
      Am J Respir Crit Care Med. 2004 Dec 15;170(12):1324-30. (PMID: 15347561)
      J Occup Environ Med. 2005 Mar;47(3):226-34. (PMID: 15761318)
      Int Arch Occup Environ Health. 2006 Jun;79(6):487-90. (PMID: 16395591)
      Chest. 2003 May;123(5):1527-35. (PMID: 12740270)
      Scand J Work Environ Health. 2020 May 1;46(3):268-277. (PMID: 31725896)
    • Contributed Indexing:
      Keywords: hypersensitivity pneumonitis; interstitial fibrosis; occupational lung disease
    • Accession Number:
      0 (Dust)
      0 (Endotoxins)
    • Publication Date:
      Date Created: 20240522 Date Completed: 20240819 Latest Revision: 20240829
    • Publication Date:
      20240830
    • Accession Number:
      PMC11347241
    • Accession Number:
      10.1136/thorax-2023-221275
    • Accession Number:
      38777581